{
    "2014-08-13": [
        "@megtirrell: $AMGN says FOCUS trial of Kyprolis didn't meet primary endpoint of improving overall survival in multiple myeloma/$LGND",
        "$AMGN FOCUS fails",
        "RT @MarketWatch: $AMGN has a double dose of bad news for investors, causing shares to drop 2% after the close"
    ]
}